154 related articles for article (PubMed ID: 1669170)
1. [Titers of antibodies against thyroid membrane antigens in patients with Graves-Basedow disease and progressive infiltrative ophthalmopathy during treatment with glucocorticoids and retro-orbital tissue irradiation].
Pilarska K; Syrenicz A; Czekalski S; Gołebiowska I; Andrzejewska W; Krzystolik Z
Pol Tyg Lek; 1991 Oct 28-Nov 4; 46(43-44):824-6. PubMed ID: 1669170
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of early and late results of progressive Graves-Basedow ophthalmopathy treatment with different methods].
Pilarska K; Czekalski S; Syrenicz A; Andrzejewska W; Krzystolik Z; Przerwa D
Pol Tyg Lek; 1992 Nov 2-9; 47(44-45):1000-3. PubMed ID: 1305709
[TBL] [Abstract][Full Text] [Related]
3. [The influence of treatment of progressive edematous infiltrative ophthalmopathy on intraocular pressure].
Rutecka-Debniak A; Krzystolik Z; Pilarska K; Krzyzanowska-Swiniarska B; Syrenicz A; Jarema A
Klin Oczna; 1999; 101(3):195-200. PubMed ID: 10526444
[TBL] [Abstract][Full Text] [Related]
4. [Individual choice of treatment in patients with progressive infiltrative ophthalmopathy in Graves-Basedow disease].
Pilarska K; Czekalski S; Syrenicz A; Andrzejewska W; Ciechanowicz A; Krzystolik Z
Pol Tyg Lek; 1993 Jul 5-12; 48(27-28):609-11. PubMed ID: 8090653
[TBL] [Abstract][Full Text] [Related]
5. E-rosette formation in Graves' ophthalmopathy.
Sergott RC; Felberg NT; Savino PJ; Blizzard JJ; Schatz NJ
Invest Ophthalmol Vis Sci; 1979 Dec; 18(12):1245-51. PubMed ID: 92464
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of Grave's ophthalmopathy with high doses of corticosteroids].
Cirić J; Zarković M; Stojanović M; Pepenezić Z; Randjelović G; Gligorović M; Trbojević B; Drezgić M; Nesović M
Srp Arh Celok Lek; 2000; 128(5-6):179-83. PubMed ID: 11089418
[TBL] [Abstract][Full Text] [Related]
7. [The effect of one-month antithyroid therapy on peripheral metabolism of reactive oxygen species in Graves' disease with infiltrative ophthalmopathy].
Bednarek J; Wysocki H; Sowiński J
Przegl Lek; 2004; 61(8):841-4. PubMed ID: 15789912
[TBL] [Abstract][Full Text] [Related]
8. Comparative study on IgG and IgA antibodies against human thyroid and eye-muscle antigens in Graves' ophthalmopathy.
Molnár I; Balázs C
Acta Med Hung; 1991; 48(1-2):13-21. PubMed ID: 1813853
[TBL] [Abstract][Full Text] [Related]
9. Extraocular muscle antibodies and the occurrence of ophthalmopathy in Graves' disease.
de Bellis A; Perrino S; Coronella C; Sansone D; Ruocco G; Tirelli G; Di Martino S; Conte M; Bellastella G; Wall JR; Bellastella A; Bizzarro A
Clin Endocrinol (Oxf); 2004 Jun; 60(6):694-8. PubMed ID: 15163332
[TBL] [Abstract][Full Text] [Related]
10. Leukocyte migration test for the study of immune reactivity in cases of Graves disease associated with infiltrative ophthalmopathy.
Kálmán K; Erdei I; Sándor P; Fazakas S; Leövey A
Acta Med Acad Sci Hung; 1978; 35(1):29-34. PubMed ID: 581631
[TBL] [Abstract][Full Text] [Related]
11. [Risk factors for occurrence of ophthalmopathy in the course of Graves-Basedow disease].
Sieradzki J; Katra B; Mirkiewicz-Sieradzka B
Przegl Lek; 2000; 57(6):321-3. PubMed ID: 11107864
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress peripheral parameters in Graves' disease: the effect of methimazole treatment in patients with and without infiltrative ophthalmopathy.
Bednarek J; Wysocki H; Sowiński J
Clin Biochem; 2005 Jan; 38(1):13-8. PubMed ID: 15607311
[TBL] [Abstract][Full Text] [Related]
13. Euthyroid infiltrative ophthalmopathy: clinical-immunological characteristics.
Kálmán K; Leövey A; Kelenhegyi C; Kolozsvári L; Bakó G
Acta Med Hung; 1989; 46(2-3):101-8. PubMed ID: 2510123
[TBL] [Abstract][Full Text] [Related]
14. The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy.
Molnár I
Autoimmunity; 2007 Feb; 40(1):31-7. PubMed ID: 17364495
[TBL] [Abstract][Full Text] [Related]
15. [The combined therapy of Basedow's ophthalmopathy with retrobulbar radiotherapy and i.v. immunoglobulins. The preliminary results].
Antonelli A; Saracino A; Alberti B; Melosi A; Cartei F; Lepri A; Laddaga M; Baschieri L
Clin Ter; 1992 Jan; 140(1):25-31. PubMed ID: 1526094
[TBL] [Abstract][Full Text] [Related]
16. Graves' ophthalmopathy and 131I therapy.
Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Mazzi B; Rocchi R; Barbesino G; Pinchera A
Q J Nucl Med; 1999 Dec; 43(4):307-12. PubMed ID: 10731781
[TBL] [Abstract][Full Text] [Related]
17. Peripheral parameters of oxidative stress in patients with infiltrative Graves' ophthalmopathy treated with corticosteroids.
Bednarek J; Wysocki H; Sowiński J
Immunol Lett; 2004 May; 93(2-3):227-32. PubMed ID: 15158621
[TBL] [Abstract][Full Text] [Related]
18. [Antibodies against TSH receptors (TRAb) as indicators in prognosing the effectiveness of Tiamazol therapy for Grave's Disease].
Bojarska-Szmygin A; Ciechanek R
Wiad Lek; 2003; 56(7-8):303-7. PubMed ID: 14969154
[TBL] [Abstract][Full Text] [Related]
19. The pathogenetic connection between Graves' disease and chronic lymphocytic thyroiditis. (The role and incidence of thyroid stimulating antibodies).
Leövey A; Bakó G; Sztojka I; Bordán L; Szabó T; Kálmán K; Balázs C
Acta Med Acad Sci Hung; 1982; 39(1-2):1-6. PubMed ID: 6129766
[TBL] [Abstract][Full Text] [Related]
20. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
